Talaporfin sodium
Cat. No.:YN481542
产品名称: | Talaporfin sodium |
CAS No.: | 220201-34-3 |
Chemical Name: | N-[2-[(7S,8S)-3-carboxy-7-(2-carboxyethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphin-5-yl]acetyl]-L-aspartic acid, tetrasodium salt |
Synonyms: | 他拉泊芬钠; ME2906; Mono-L-aspartyl chlorin e6; NPe6 |
分子量: | 799.69 |
分子式: | C₃₈H₃₇N₅Na₄O₉ |
SMILES: | O=C(O[Na])C[C@@H](C(O[Na])=O)NC(C/C1=C2[C@@H](CCC(O[Na])=O)[C@H](C)C(/C=C3C(C)=C(C=C)/C(N/3)=C/C(C(C)=C/4CC)=NC4=C/C5=C(C)C(C(O[Na])=O)=C1N5)=N\2)=O |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Talaporfin (ME2906; NPe6)钠盐是光动力学疗法(PDT)中的一种光敏剂。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Dennis, E.J., Dolmans, G.J., Fukumura, D., et al.Photodynamic therapy for cancerNature3,1-8(2003)
Ohashi, S., Kikuchi, O., Tsurumaki, M., et al.Preclinical validation of talaporfin sodium-mediated photodynamic therapy for esophageal squamous cell carcinomaPLoS One9(8),e103126(2014)